Jaguar Animal Health Stock Today
| JAGX Stock | USD 1.04 0.04 4.00% |
Performance0 of 100
| Odds Of DistressOver 83
|
Jaguar Animal is trading at 1.04 as of the 30th of November 2024; that is 4.00 percent increase since the beginning of the trading day. The stock's open price was 1.0. Jaguar Animal has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Jaguar Animal Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of May 2015 | Category Healthcare | Classification Health Care |
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California. The company has 11.8 M outstanding shares of which 430.73 K shares are currently shorted by private and institutional investors with about 1.12 trading days to cover. More on Jaguar Animal Health
Moving together with Jaguar Stock
Moving against Jaguar Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Jaguar Stock Highlights
| CEO and President and Director | Lisa Conte | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsJaguar Animal can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Jaguar Animal's financial leverage. It provides some insight into what part of Jaguar Animal's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jaguar Animal Health (JAGX) is traded on NASDAQ Exchange in USA. It is located in 200 Pine Street, San Francisco, CA, United States, 94104 and employs 49 people. Jaguar Animal is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.27 M. Jaguar Animal Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.8 M outstanding shares of which 430.73 K shares are currently shorted by private and institutional investors with about 1.12 trading days to cover.
Jaguar Animal Health currently holds about 9.01 M in cash with (33.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Jaguar Animal Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Jaguar Animal is $12.27 Million. Jaguar Animal retains 12.02 (percent) of its outstanding shares held by insiders and 1.95 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Jaguar Ownership Details
Jaguar Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Susquehanna International Group, Llp | 2024-06-30 | 0.0 | |
| Ica Group Wealth Management, Llc | 2024-06-30 | 0.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Jane Street Group Llc | 2024-06-30 | 0.0 | |
| Perritt Capital Management Inc. | 2024-09-30 | 0.0 | |
| Fidelity Management And Research Company | 2024-06-30 | 0.0 | |
| Ubs Group Ag | 2024-06-30 | 0.0 | |
| Csenge Advisory Group, Llc | 2024-06-30 | 0.0 | |
| Two Sigma Investments Llc | 2024-06-30 | 0.0 | |
| Geode Capital Management, Llc | 2024-09-30 | 81.8 K | |
| Vanguard Group Inc | 2024-09-30 | 59.5 K |
Jaguar Animal Historical Income Statement
Jaguar Stock Against Markets
Jaguar Animal Corporate Management
| Steven King | Executive VP of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary | Profile | |
| DVM MS | VP Studies | Profile | |
| Ian MBA | Chief Officer | Profile | |
| Pravin Chaturvedi | Chief Board | Profile | |
| Peter Hodge | Business Relations | Profile | |
| Carol MBA | Chief Officer | Profile | |
| Karen Brunke | Executive Development | Profile |
Additional Tools for Jaguar Stock Analysis
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.